Igc Pharma Inc (IGC) Stock Price, Quote & News

Company Profile

IGC Pharma, Inc., a clinical stage pharmaceutical company, develops treatments for Alzheimer's disease in the United States and Colombia. The company's lead product is IGC-AD1 that is in Phase II clinical trial for the treatment of agitation in dementia due to Alzheimer's. Its pre-clinical stage product candidate includes TGR-63, IGC-M3, and LMP to treat Alzheimer's disease; IGC-1C for the treatment of metabolic disorders and Alzheimer's disease; and IGC-1A to treat metabolic disorders. The comp...

Industry: Biotechnology

Sector: Healthcare

Phone: 301 983 0998

Website: igcpharma.com

Address:

10224 Falls Road, Potomac, United States

RealJonDo Oct. 2 at 5:03 PM

$IGC break and retest of trend.. Holding above 21 and 50 EMA. Lets see if we could hold and push before EOW.

0 · Reply

GPusicat Sep. 30 at 1:56 PM

$IGC i cant remind that this ever hold pm SP during trading session.

0 · Reply

Findingthebull Sep. 30 at 1:33 PM

$IGC Holding this long term. Have to be patient with this one.

0 · Reply

Ottersberger Sep. 30 at 12:27 PM

$IGC when 4$ ?

0 · Reply

BigSqueezeComing Sep. 30 at 8:35 AM

$IGC Something is happening here. PM gappers.

0 · Reply

GPusicat Sep. 30 at 8:20 AM

$IGC why it is up PM.Any news?

0 · Reply

UCIdidmyDD Sep. 30 at 4:53 AM

$TLRY $MSOX $IGC $YCBD make sure you dd igc. it doesnt have the hype machine of the canadian names. 10-100x potential too

0 · Reply

spacsaholic Sep. 29 at 9:13 PM

$MLTX $BURU $IOBT $VIVK $IGC

0 · Reply

walfofwallstreet Sep. 29 at 9:09 PM

After hours fire🔥list🔥👀👀🐺 $MLTX $BURU $IOBT $VIVK $IGC Let’s go 💰💵💰 Stay tuned everyone 👀🐺 All my followers are making bank 🏦 You all gonna be rich 🤑

1 · Reply

walfofwallstreet Sep. 29 at 8:55 PM

After hours fire🔥list🔥👀👀🐺 $MLTX $IOBT $IGC $VIVK $EPOW Let’s go 💰💵💰 Stay tuned everyone 👀🐺 All my followers are making bank 🏦 You all gonna be rich 🤑

1 · Reply

IGC Pharma Adds Ichor Research as New Site for CALMA Phase 2 Alzheimer's Trial

Sep 24, 2025, 9:00 AM EDT - 10 days ago

IGC Pharma Announces Preclinical Data Demonstrating TGR-63's Dual Action on Alzheimer's Pathology

Sep 22, 2025, 9:00 AM EDT - 12 days ago

IGC Pharma Reports 50% Patient Enrollment Milestone in Phase 2 CALMA Alzheimer's Agitation Trial

Sep 9, 2025, 9:00 AM EDT - 25 days ago

IGC Pharma, Inc. Receives Third Award from the NIA for Excellence in Code Clarity, Reproducibility, and Usability for Alzheimer's Detection

Sep 2, 2025, 9:00 AM EDT - 4 weeks ago

IGC Pharma Expands CALMA Phase 2 Trial to Island Health's Royal Jubilee Hospital in Canada

Aug 28, 2025, 9:00 AM EDT - 5 weeks ago

IGC Pharma receives Notice of Allowance for Novel THC Microdose-Based Treatment for Stammering, Stuttering, and Tourette's Syndrome

Aug 27, 2025, 9:00 AM EDT - 5 weeks ago

IGC Pharma Announces Coverage Report by Ascendiant Capital Markets about the "Reports Q1 results. We believe more positive clinical data and progress in 2025 to be strong catalysts for stock.

Aug 25, 2025, 9:00 AM EDT - 5 weeks ago

IGC Pharma Expands CALMA Phase 2 Trial with Site at Lynn Health Science Institute in Oklahoma City

Aug 19, 2025, 9:00 AM EDT - 6 weeks ago

IGC Pharma Reports First Quarter Fiscal 2026 Financial Results; Company Accelerates Phase 2 Alzheimer's Trial

Aug 12, 2025, 9:00 AM EDT - 7 weeks ago

IGC Pharma Highlights Alzheimer's Pipeline with Encouraging Preclinical Data on IGC-M3 and Advancing Phase 2 Cannabinoid-Based IGC-AD1

Aug 5, 2025, 9:00 AM EDT - 2 months ago

IGC Pharma Reports IGC-M3's In Vitro Efficacy Against Alzheimer's - Targeting key Drivers of Disease Progression

Jul 23, 2025, 9:00 AM EDT - 2 months ago

IGC Pharma to Present Advanced AI Platforms for Alzheimer's Disease at the AAIC 2025

Jul 21, 2025, 9:00 AM EDT - 2 months ago

IGC Pharma's Principal Scientist Dr. Jagadeesh Rao Receives Best Researcher Award at 11th Annual World Neuroscience Awards

Jul 10, 2025, 3:10 PM EDT - 3 months ago

IGC Pharma Introduces MINT-AD: Proprietary AI Platform to Predict Alzheimer's Risk and Accelerate Early Detection

Jun 30, 2025, 9:00 AM EDT - 3 months ago

IGC Pharma: Fiscal Year 2025 Financial and Operational Highlights - A Year of Transformative Progress in Alzheimer's Innovation

Jun 27, 2025, 8:30 AM EDT - 3 months ago

IGC Pharma to Host Fiscal Year-End 2025 Shareholder Update Call on Monday June 30, 2025

Jun 23, 2025, 8:30 AM EDT - 3 months ago

IGC Pharma Expands CALMA Trial to Oklahoma, Partnering with Dr. David McCoy at Tekton Research in Yukon

May 22, 2025, 9:30 AM EDT - 4 months ago

IGC Pharma's Puerto Rico CALMA Trial Site Offers Strategic Opportunity in High-Prevalence Alzheimer's Market

May 12, 2025, 9:30 AM EDT - 5 months ago

IGC Pharma Presents Genetic Toxicology Safety Data on API in IGC-AD1, at the 2025 Genetic Toxicology Association Meeting

Apr 24, 2025, 9:30 AM EDT - 5 months ago

IGC Pharma Welcomes Strategic Investment from Advisors

Apr 21, 2025, 9:30 AM EDT - 5 months ago

IGC Pharma Welcomes Industry Leaders to Advisory Board, Supporting Alzheimer's Innovation and AI-Driven Programs

Apr 8, 2025, 9:30 AM EDT - 6 months ago

IGC Pharma Expands CALMA Alzheimer's Phase 2 Trial with Prestigious Research Site at Butler Hospital's Memory and Aging Program

Apr 1, 2025, 9:00 AM EDT - 6 months ago

IGC Pharma Announces CALMA Phase 2 Trial Expansion with the Addition of Miami Jewish Health

Mar 26, 2025, 9:00 AM EDT - 6 months ago

IGC Pharma's Phase 2 Clinical Trial Interim Data Demonstrates Significant Reduction in Sleep Disturbances

Mar 20, 2025, 9:00 AM EDT - 7 months ago

IGC Pharma Announces CALMA Phase 2 Trial Expansion with the Addition of Canadian Hamilton Health Sciences

Mar 17, 2025, 9:00 AM EDT - 7 months ago

IGC Pharma Expands CALMA Trial with Addition of BayCare Health System in Florida

Mar 12, 2025, 9:00 AM EDT - 7 months ago

IGC Pharma Announces Coverage Report by Ascendiant Capital Markets about the "Reports Q3 results. We believe more positive clinical data in 2025 to be strong catalysts for stock.

Mar 10, 2025, 9:00 AM EDT - 7 months ago

IGC Pharma Announces Equity Analyst Update by Alliance Global Partners (AGP) about the "Progressing Alzheimer-targeting efforts with notable Phase 2 CALMA interim results"

Mar 4, 2025, 9:00 AM EST - 7 months ago

IGC Pharma Expands AI Platform With Advanced Diagnostic Model for Alzheimer's and Dementia Detection

Feb 20, 2025, 9:00 AM EST - 8 months ago

IGC Pharma Expands Holiby(TM) Product Line With 'Longevity' and 'Renew' - Targeting the Multi-Billion-Dollar Anti-Aging Market

Feb 18, 2025, 8:30 AM EST - 8 months ago

IGC Pharma Reports Third Quarter Fiscal 2025 Results

Feb 11, 2025, 8:30 AM EST - 8 months ago

IGC Pharma Expands Into $75 Billion Wellness Market with the Launch of Holiby(TM)

Jan 28, 2025, 8:30 AM EST - 8 months ago

IGC Pharma Named Top 15 Finalist in NIA PREPARE Challenge for AI-Driven Early Detection of Alzheimer's Disease

Jan 13, 2025, 8:30 AM EST - 9 months ago

IGC Pharma to Participate in Fireside Chat with Ascendiant Capital Markets

Jan 8, 2025, 8:30 AM EST - 9 months ago

IGC Pharma Names IGC-AD1 Phase 2 Clinical Trial for Alzheimer's Agitation "CALMA" and Expands Recruitment Strategy

Dec 19, 2024, 7:00 PM EST - 10 months ago

IGC Pharma Announces Participation in BioPartnering at JPM Alongside the J.P. Morgan 43rd Annual Healthcare Conference 2025

Dec 2, 2024, 8:30 AM EST - 10 months ago

IGC Pharma Advances IGC-AD1 as a Potential Alzheimer's Therapy Addressing Cognitive Impairment and Underlying Disease Pathology

Nov 25, 2024, 8:30 AM EST - 11 months ago

IGC Pharma Announces Additional Phase 2 Interim Results Highlighting Cognitive Benefits of IGC-AD1 for Alzheimer's Treatment

Nov 14, 2024, 8:30 AM EST - 11 months ago

IGC Pharma Reports Second Quarter Fiscal 2025 Results, Showcasing Progress in Its Alzheimer's Pipeline

Nov 6, 2024, 8:30 AM EST - 11 months ago

IGC Pharma Announces Publication of IMS Spotlight Interview Highlighting Strategic Expansion in Alzheimer's and Weight Loss Therapies

Oct 17, 2024, 8:30 AM EDT - 1 year ago

IGC Pharma Announces Patient Enrollment at Toronto's Baycrest in Phase 2 Trial Investigating IGC-AD1

Oct 3, 2024, 9:00 AM EDT - 1 year ago

IGC Pharma Wins 2 Prizes in Phase 1 of National Institutes of Health's AI PREPARE Challenge

Sep 18, 2024, 8:00 AM EDT - 1 year ago

IGC Pharma Announces Additional Data Supporting IGC-AD1 as an Alzheimer's Treatment

Sep 4, 2024, 8:00 AM EDT - 1 year ago

IGC Pharma Advances IGC-AD1 Toward Clinical Trials as a Potential anti-Amyloid Plaque Treatment for Alzheimer's Disease

Aug 22, 2024, 9:00 AM EDT - 1 year ago

IGC Pharma Announces Research Demonstrating New Molecule IGC-1C Targets Tau Protein in Alzheimer's Disease

Aug 8, 2024, 9:30 PM EDT - 1 year ago

IGC Pharma Reports First Quarter Fiscal 2025 Results

Jul 18, 2024, 9:00 AM EDT - 1 year ago

IGC Pharma Announces Equity Analyst Coverage by Alliance Global Partners (AGP) with a "Buy" Recommendation and $3.50 Price Target

Jul 9, 2024, 9:10 AM EDT - 1 year ago

Preclinical Analyses of TGR-63 Demonstrate Blood-Brain Barrier Permeability and Safety Profile

Jun 25, 2024, 9:00 AM EDT - 1 year ago

IGC Pharma's TGR-63 Preclinical Results Show Substantial Reduction in Amyloid Plaque, a Key Hallmark of Alzheimer's Disease

Jun 10, 2024, 9:00 AM EDT - 1 year ago

IGC Pharma Publishes Study in European Society of Medicine Investigating the Impact of CYP2C9 Genetic Polymorphism on Pharmacokinetics of Delta 9 Tetrahydrocannabinol

RealJonDo Oct. 2 at 5:03 PM

$IGC break and retest of trend.. Holding above 21 and 50 EMA. Lets see if we could hold and push before EOW.

0 · Reply

GPusicat Sep. 30 at 1:56 PM

$IGC i cant remind that this ever hold pm SP during trading session.

0 · Reply

Findingthebull Sep. 30 at 1:33 PM

$IGC Holding this long term. Have to be patient with this one.

0 · Reply

Ottersberger Sep. 30 at 12:27 PM

$IGC when 4$ ?

0 · Reply

BigSqueezeComing Sep. 30 at 8:35 AM

$IGC Something is happening here. PM gappers.

0 · Reply

GPusicat Sep. 30 at 8:20 AM

$IGC why it is up PM.Any news?

0 · Reply

UCIdidmyDD Sep. 30 at 4:53 AM

$TLRY $MSOX $IGC $YCBD make sure you dd igc. it doesnt have the hype machine of the canadian names. 10-100x potential too

0 · Reply

spacsaholic Sep. 29 at 9:13 PM

$MLTX $BURU $IOBT $VIVK $IGC

0 · Reply

walfofwallstreet Sep. 29 at 9:09 PM

After hours fire🔥list🔥👀👀🐺 $MLTX $BURU $IOBT $VIVK $IGC Let’s go 💰💵💰 Stay tuned everyone 👀🐺 All my followers are making bank 🏦 You all gonna be rich 🤑

1 · Reply

walfofwallstreet Sep. 29 at 8:55 PM

After hours fire🔥list🔥👀👀🐺 $MLTX $IOBT $IGC $VIVK $EPOW Let’s go 💰💵💰 Stay tuned everyone 👀🐺 All my followers are making bank 🏦 You all gonna be rich 🤑

1 · Reply

Dsing038 Sep. 29 at 8:27 PM

$EPOW $IGC $MLTX $PSTV $TLRY

0 · Reply

walfofwallstreet Sep. 29 at 8:27 PM

After hours fire🔥list🔥👀👀🐺 $MLTX $IGC $TLRY $PSTV $EPOW Let’s go 💰💵💰 Stay tuned everyone 👀🐺 All my followers are making bank 🏦 You all gonna be rich 🤑

3 · Reply

laurenlee Sep. 29 at 8:20 PM

$EPOW $IGC $MLTX $PSTV $SPRC This guy pump and dumper

1 · Reply

walfofwallstreet Sep. 29 at 8:15 PM

After hours fire🔥list🔥👀👀🐺 $MLTX $IGC $PSTV $SPRC $EPOW Let’s go 💰💵💰 Stay tuned everyone 👀🐺 All my followers are making bank 🏦 You all gonna be rich 🤑

1 · Reply

TheLionofwallstreet Sep. 29 at 7:40 PM

$IGC this one is sleeping. Morning up 10%

0 · Reply

instafuad Sep. 29 at 2:16 PM

$IGC Come on

0 · Reply

hardrock2112 Sep. 29 at 1:13 PM

$IGC

0 · Reply

UCIdidmyDD Sep. 26 at 5:34 AM

$TLRY $VFF $IGC

1 · Reply

1AMBITIOUSSAVAGE Sep. 25 at 10:10 PM

$STFS Is a beast !! I see that it can run like $SKBL IMO Premarket will be interesting. Don’t forget $EZGO $IGC 4pt. 🎯

0 · Reply

Golferhack12 Sep. 25 at 8:21 PM

$IGC I would never ever want a company to do a reverse split but in this case because the stock simply does not move and there's 90 million shares I think they should do a one for four reverse split it'll perform better

2 · Reply

BioTuesdays Sep. 24 at 6:31 PM

$IGC has announced preclinical findings on its investigational small molecule candidate for Alzheimer’s disease (AD) demonstrating that TGR-63 extends its therapeutic potential beyond previously reported effects on beta-amyloid (Aβ) pathology by also inhibiting tau protein aggregation, another key hallmark of Alzheimer’s https://biotuesdays.com/2025/09/24/igc-announces-pre-clinical-data-for-tgr-63-in-ad/

0 · Reply

hardrock2112 Sep. 24 at 1:05 PM

$IGC

0 · Reply

Market Cap	37.31M
Revenue (ttm)	1.27M
Net Income (ttm)	-7.12M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-560.63%
Debt to Equity Ratio	0.02

Volume	408,400
Avg Vol	932,366
Day's Range	N/A - N/A
Shares Out	91.96M
Stochastic %K	36%
Beta	1.04
Analysts	Sell
Price Target	$3.75